Regrowth Labs® D5A is a pharmaceutical-grade topical serum containing dutasteride USP 0.5%, Azelaic Acid, Trichogen, and Propanediol delivery technology. As a topical treatment, D5A delivers targeted DHT-blocking activity at the scalp with lower systemic exposure than oral alternatives. Postmenopausal women with androgenetic alopecia are the primary candidates. Available in the UAE at AED 305.00 from Hims N Hers.
Hair loss is not a condition that affects men alone. According to the American Hair Loss Association, women constitute 40% of hair loss sufferers — yet they remain significantly underserved by both the medical community and the hair care market. Fewer than 45% of women go through life with a full head of hair, and female pattern hair loss (FPHL) — also known as androgenetic alopecia — is the most common cause, with a clinical prevalence of 32.3% according to research published in the Journal of the American Academy of Dermatology.
Despite how widespread it is, FPHL is frequently under-diagnosed and poorly managed. Many women are told to try a single topical option, given minimal explanation of the underlying biology, and left without a clear path forward when first-line treatments underdeliver. The core issue is the same in women as in men: dihydrotestosterone (DHT), an androgen produced from testosterone by the enzyme 5α-reductase, miniaturizes genetically susceptible hair follicles over time, shortening the growth cycle and ultimately reducing hair density.
For postmenopausal women — and selected premenopausal women under appropriate medical supervision — pharmaceutical-grade DHT-blocking therapy offers a more targeted approach. This guide covers what the Regrowth Labs® D5A Hair Regrowth Treatment contains, how dutasteride applies to women’s hair loss, who D5A is appropriate for, and how it compares to other options currently available in the UAE.
What Is the D5A Hair Regrowth Treatment?
Regrowth Labs® D5A is a pharmaceutical-grade topical hair regrowth serum formulated to address androgenetic alopecia at its biological root. The treatment combines the highest purity Dutasteride USP 0.5% with Azelaic Acid — two clinically recognized 5α-reductase inhibitors — to prevent the enzymatic conversion of testosterone into DHT at the scalp.
Unlike topical solutions that address only the crown, D5A is designed to treat the entire scalp. Both the vertex and the hairline receive active treatment simultaneously, which matters for women experiencing diffuse thinning — the most common presentation of FPHL — where hair loss is distributed broadly across the scalp rather than concentrated in one zone.
The formula also contains Trichogen, a patented multi-component complex that supports scalp microcirculation, and Propanediol, a plant-based delivery vehicle that replaces petroleum-derived Propylene Glycol. The result is a clean, high-performance serum free from petroleum derivatives, mineral oil, paraffin, fragrance, sulfates, and parabens.
D5A is available exclusively online through Hims N Hers UAE, priced at AED 305.00 per bottle.
Key Active Ingredients in D5A
Each component in the D5A formula addresses a specific, evidence-based mechanism involved in hair follicle miniaturization and regrowth.
Dutasteride USP 0.5%
Dutasteride is the most potent clinically studied 5α-reductase inhibitor available. It differs from finasteride — the better-known hair loss drug — in one critical way: dutasteride inhibits both Type II and Type III isoforms of the 5α-reductase enzyme, whereas finasteride targets only Type II. Because both isoforms contribute to DHT production in the scalp, dutasteride delivers a more comprehensive DHT blockade — reducing scalp and serum DHT by approximately 90–95%, compared with approximately 70% for finasteride.
A three-year retrospective study by Boersma et al., published in the Indian Journal of Dermatology, Venereology and Leprology (2014), drew on a database of 3,500 women treated for androgenetic alopecia. In the dutasteride group, 83.3% of patients demonstrated measurable improvement in hair thickness, and expert reviewers rated post-treatment images as showing superior density in 65.6% of cases. Dutasteride outperformed finasteride specifically in women under 50 at the central and vertex scalp sites.
In the D5A formulation, dutasteride is present at pharmaceutical USP-grade purity — the same standard used in licensed pharmaceutical manufacturing — ensuring consistent potency and bioavailability in each application.
Azelaic Acid
Azelaic Acid functions as a complementary DHT inhibitor within D5A. As a naturally occurring dicarboxylic acid, Azelaic Acid has been studied for its ability to inhibit 5α-reductase activity at the follicular level and reduce local DHT concentrations in the scalp. Its presence alongside dutasteride creates a dual-pathway inhibition strategy: broad DHT suppression via dutasteride, reinforced by localized follicular inhibition through Azelaic Acid. For women with diffuse androgenetic thinning across multiple scalp zones, this layered approach is a meaningful structural advantage.
Trichogen
Trichogen is a patented active ingredient that targets hair loss at the cellular level. Its primary functions include decreasing hair shedding, stimulating hair growth, activating scalp metabolism, and improving cellular oxygenation and microcirculation within the scalp’s dermal layer.
Scalp microcirculation — the movement of blood through the capillaries supplying the dermal papilla — is a recognized contributing factor in androgenetic alopecia. Impaired blood flow limits the oxygen and nutrient delivery that follicles require to sustain the anagen (growth) phase. By supporting microcirculation, Trichogen helps create conditions that are more conducive to active follicle function and hair shaft production.
Propanediol and Delivery Technology
Pharmaceutical-grade active ingredients are only as effective as the system that delivers them to the target tissue. D5A addresses this with Propanediol — a natural, plant-based, skin-friendly alternative to petroleum-based Propylene Glycol — combined with proprietary nanosome encapsulation technology and transdermal enhancers.
Propanediol delivers actives with enhanced absorption and no skin irritation, making it significantly more tolerable for daily use. The nanosome encapsulation technology further ensures that active compounds penetrate more deeply into the scalp, maximizing delivery to the follicle zone. This is particularly relevant for the scalp’s outer barrier, which limits the penetration of many conventional topical formulations.
Can Women Use Dutasteride for Hair Loss?
The short answer is yes — under appropriate medical supervision and with a clear understanding of the candidacy criteria.
Dutasteride is not FDA-approved for female hair loss. Any use in women is considered off-label, which is both legal and common in dermatology, but raises the bar on informed consent and patient selection. The key distinction between oral and topical dutasteride is systemic exposure: applied to the scalp, significantly less of the drug enters the bloodstream compared to an oral capsule, which is why topical formulations like D5A are considered to carry a lower systemic side effect profile than oral alternatives.
The most important contraindication is pregnancy. Dutasteride is FDA Pregnancy Category X. The drug must not be used by women who are pregnant, planning pregnancy, or could become pregnant, because it can cause developmental abnormalities in a male fetus. This contraindication applies to both oral and topical forms — the drug absorbs through skin contact, and appropriate precautions during handling are essential.
Postmenopausal women represent the most appropriate candidate group. With pregnancy no longer possible, the primary contraindication is eliminated, and the balance of benefit to risk becomes considerably more favorable. It is worth noting that FPHL becomes more prevalent with age, affecting up to 40% of women between the ages of 60 and 69, according to Herskovitz and Tosti (2013) — precisely the demographic for whom the risk profile of dutasteride is most manageable.
For premenopausal women, off-label use is possible in selected cases but requires reliable contraception throughout treatment, a minimum six-month contraception period after stopping, and evaluation by a qualified healthcare provider.
Women whose hair loss is driven by thyroid dysfunction, iron deficiency, telogen effluvium, or autoimmune conditions — rather than DHT sensitivity — will not benefit from a DHT-blocking approach. An accurate diagnosis is a necessary first step before beginning any anti-androgen therapy.
Who Is D5A For? Women’s Guidance
D5A is a topical DHT-blocking serum best suited to women with confirmed androgenetic alopecia (female pattern hair loss) who are experiencing progressive diffuse thinning linked to DHT sensitivity.
The treatment is most appropriate for:
- Postmenopausal women with confirmed FPHL or frontal fibrosing alopecia (FFA) who want a pharmaceutical-grade topical option
- Women who have not achieved sufficient improvement from minoxidil alone and are seeking a DHT-targeting approach under medical guidance
- Women who prefer a topical application over oral dutasteride or oral antiandrogens, due to lower systemic exposure
- Women committed to consistent, long-term use — clinical studies assess DHT-blocking outcomes at 12 to 24 weeks minimum, with continued improvement documented at three years
D5A is not appropriate for women who are pregnant, potentially pregnant, or actively trying to conceive. Women with a history of hormone-sensitive cancers, active liver disease, or known hypersensitivity to 5α-reductase inhibitors should consult their physician before use.
As with all pharmaceutical-grade hair loss treatments, beginning D5A should follow a proper diagnosis — ideally including blood work and a trichological evaluation — to confirm that the pattern of hair loss is androgen-driven before committing to a DHT-inhibition strategy.
How D5A Compares to Other Women’s Hair Loss Treatments in the UAE
Several options are available to women managing hair loss in the UAE. Understanding where D5A sits relative to those alternatives helps clarify when it may be the right choice.
Minoxidil (topical) remains the only FDA-approved treatment for female pattern hair loss and is typically the first-line recommendation from dermatologists. Minoxidil works by extending the anagen phase of the hair cycle and improving follicular blood flow — but it does not reduce DHT. For women whose hair loss is androgen-driven, minoxidil addresses the symptom rather than the hormonal cause, which can limit long-term outcomes.
Spironolactone is an oral antiandrogen commonly prescribed off-label for FPHL. It blocks androgen receptors, reducing the binding of both testosterone and DHT to follicle receptors, and also reduces ovarian androgen production. Spironolactone has a larger body of female-specific clinical data than dutasteride and a much shorter half-life, which means side effects resolve faster if the medication is stopped. Most dermatologists consider it the first oral option before dutasteride for premenopausal women.
Finasteride (oral or topical) inhibits only Type II 5α-reductase and reduces DHT by approximately 70%. The Boersma 2014 study found dutasteride outperformed finasteride in women under 50, particularly at the central and vertex scalp, because of dutasteride’s broader dual-isoform inhibition.
D5A (topical dutasteride USP 0.5%) offers the most comprehensive DHT blockade available in a topical formulation, with the added benefit of Azelaic Acid’s localized inhibitory effect, Trichogen’s microcirculation support, and nanosome delivery technology for deeper follicular penetration. Because it is applied directly to the scalp, systemic exposure is lower than with oral dutasteride — an important consideration for women who are appropriate candidates but want to minimize the risk of hormonal side effects.
For women who have maximized minoxidil’s benefit and are postmenopausal or under appropriate medical supervision, D5A represents a logical next step or addition to an existing hair loss protocol.
Where to Buy Regrowth Labs D5A Online in Dubai
Regrowth Labs D5A online Dubai and across the UAE is available exclusively through Hims N Hers UAE — a dedicated online hair care retailer serving the UAE community. The purchasing process is straightforward: visit the product page, select your quantity, and proceed through the secure online checkout. The platform supports both add-to-cart and buy-now functionality.
For questions about whether D5A is appropriate for your specific hair loss pattern, the Hims N Hers team is available via WhatsApp at +971 56 547 5893 and typically responds within minutes.
Price: AED 305.00 per bottle
Frequently Asked Questions
Can women use Regrowth Labs D5A for hair loss?
D5A may be appropriate for women with confirmed androgenetic alopecia, particularly postmenopausal women. As a topical formulation, D5A delivers dutasteride with lower systemic exposure than oral options. Use should always follow medical evaluation to confirm the hair loss is DHT-driven and to verify candidacy. Women who are pregnant or could become pregnant must not use D5A.
Is topical dutasteride safer than oral dutasteride for women?
Topical application delivers significantly less drug to the bloodstream than an oral capsule, which generally translates to a lower systemic side effect profile. The pregnancy contraindication still applies — dutasteride absorbs through skin contact — but for postmenopausal women concerned about hormonal side effects, a topical formulation like D5A is a meaningful alternative to oral dutasteride.
How long does D5A take to show results in women?
Hair regrowth treatments operate on the biological timescale of the hair growth cycle. Clinical studies measuring DHT-blocking outcomes typically assess results at 12 to 24 weeks of consistent daily use. The three-year Boersma study documented hair thickness improvement in 83.3% of women on dutasteride 0.15mg daily — confirming that sustained use produces cumulative benefit over time.
What are the side effects of dutasteride in women?
The most commonly reported side effects include reduced libido, breast tenderness, and hormonal shifts. Premenopausal women may also experience menstrual irregularity. Most side effects are reversible after stopping treatment, though dutasteride’s approximately five-week half-life means resolution takes weeks rather than days. Any new or persistent symptoms should be reported to a healthcare provider.
Can D5A be combined with minoxidil for women?
Dutasteride and minoxidil work through different mechanisms — DHT inhibition and anagen phase extension, respectively — making them pharmacologically complementary. Combining the two approaches is a strategy commonly used in clinical practice. Consult a healthcare provider before combining treatments to ensure the combination is appropriate for your specific case.
Who should not use D5A?
D5A is not appropriate for women who are pregnant, planning pregnancy, or could become pregnant. Additional contraindications include a history of hormone-sensitive cancers, active liver disease, and known hypersensitivity to 5α-reductase inhibitors. Women whose hair loss is caused by thyroid dysfunction, iron deficiency, or autoimmune conditions will not benefit from a DHT-blocking approach, reinforcing the importance of an accurate diagnosis before beginning treatment.
Where can I buy D5A in the UAE?
D5A is available for purchase through Hims N Hers UAE. You can order directly online and receive delivery across Dubai and the UAE. The team is also reachable via WhatsApp at +971 56 547 5893 for pre-purchase consultation.
Take a Clinically Grounded Approach to Women’s Hair Loss
Female pattern hair loss is progressive. The longer DHT-driven follicular miniaturization continues unchecked, the more challenging recovery becomes. For women who have confirmed androgenetic alopecia, particularly those who are postmenopausal or under appropriate medical supervision, a pharmaceutical-grade topical DHT-blocking serum offers a targeted, evidence-supported path forward.
Regrowth Labs® D5A brings together Dutasteride USP 0.5%, Azelaic Acid, Trichogen, and nanosome delivery technology in a clean, full-scalp formulation designed for daily use. Priced at AED 305.00, it represents one of the most clinically substantive topical hair loss options available in the UAE.
To learn more or place an order, visit the Regrowth Labs D5A online Dubai product page on Hims N Hers UAE, or contact the team on WhatsApp at +971 56 547 5893.